201
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Real-world data of the use of rivaroxaban in pediatric patients with hematologic malignancies

, , , , , & show all
Pages 538-540 | Received 01 Aug 2023, Accepted 25 Dec 2023, Published online: 03 Jan 2024
 

Disclosure statement

No potential conflict of interest was reported by the author(s).

Additional information

Funding

MCPM and THT are supported by a grant from the Fonds de Recherche en Santé du Québec (Junior 1). Fonds de Recherche du Québec - Santé.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,065.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.